talking about abbvie, my cousin who is a chemist for 20 years at Allergan was laid-off 3 weeks ago when abbvie bought them out. The new employees were kept, but he has a great severance package and cobra for a year. In due time we will be bought out too.
A $4 to $20 billion apples to pineapples question?
Genmab is already a roughly $20 billion company. (Anchor that price everyone!)
It’s a development and commercialization deal worth almost $4 Billion for 3 early stage bispecific antibodies for blood cancers that haven’t even made it to phase 1 trials.
I thought it was a generous deal, given GMAB shares profits 50:50 in US and Japan, potentially worth billions, and gets up to 26% royalties from ABBV using its muscle and worldwide network of blond drug reps to sell to the rest of the world.
News 
Market Data 
Discover 
